Diabetic vitreous hemorrhage is linked to neuropathologic changes in specific brain regions, as identified by voxel-based ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

Sienna Eye Care will provide personalized solutions for eye conditions such as dry eyes, glaucoma, macular pediatric degeneration and diabetic retinopathy. It also will provide pediatric evaluations ...

EyePoint (EYPT) stock rose 10% after the company reported six-month results from a phase 2 study of its drug Duravyu in the treatment of diabetic macular edema. Read more here.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Background: This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR) in type 2 diabetic patients and their contributing factors. Methods: 199 type 2 ...

Good' (HDL) cholesterol, usually considered to be beneficial for health, may be linked to a heightened risk of the serious ...

Drug distributor Cencora raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines.

Leerink Partners upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a market perform rating to an ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

THIRUVANANTHAPURAM: Chief Minister Pinarayi Vijayan on Wednesday released a textbook on diabetes management, published by ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.